Total Payments
$345,139
2024 Payments
$65,056
Companies
70
Transactions
2,240
Medicare Patients
2,525
Medicare Billing
$817,489
Payment Breakdown by Category
Other$254,487 (73.7%)
Food & Beverage$40,638 (11.8%)
Travel$29,100 (8.4%)
Consulting$20,895 (6.1%)
Education$20.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $217,562 | 137 | 63.0% |
| Food and Beverage | $40,638 | 1,882 | 11.8% |
| Travel and Lodging | $29,100 | 187 | 8.4% |
| Honoraria | $24,750 | 11 | 7.2% |
| Consulting Fee | $20,895 | 10 | 6.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,519 | 8 | 3.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,656 | 1 | 0.5% |
| Education | $20.00 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $86,512 | 327 | $0 (2022) |
| UCB, Inc. | $81,587 | 348 | $0 (2024) |
| ABBVIE INC. | $55,178 | 322 | $0 (2024) |
| SK Life Science, Inc. | $34,705 | 223 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $23,194 | 46 | $0 (2024) |
| LivaNova USA, Inc. | $19,983 | 112 | $0 (2024) |
| Eisai Inc. | $10,038 | 75 | $0 (2024) |
| AQUESTIVE THERAPEUTICS, INC. | $7,320 | 28 | $0 (2022) |
| Cyberonics, Inc. | $6,701 | 29 | $0 (2017) |
| UCB SA | $4,511 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,056 | 356 | ABBVIE INC. ($27,072) |
| 2023 | $42,232 | 302 | AbbVie Inc. ($12,827) |
| 2022 | $27,104 | 320 | ABBVIE INC. ($7,421) |
| 2021 | $28,614 | 334 | AbbVie Inc. ($7,858) |
| 2020 | $34,478 | 288 | SK Life Science, Inc. ($15,455) |
| 2019 | $19,358 | 202 | EISAI INC. ($5,132) |
| 2018 | $59,121 | 255 | Sunovion Pharmaceuticals Inc. ($27,267) |
| 2017 | $69,176 | 183 | Sunovion Pharmaceuticals Inc. ($55,370) |
All Payment Transactions
2,240 individual payment records from CMS Open Payments — Page 1 of 90
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: PAIN | ||||||
| 12/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 12/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $7.93 | General |
| 12/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $6.73 | General |
| 12/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $3.28 | General |
| 12/18/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: PAIN | ||||||
| 12/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: EPILEPSY | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $123.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.94 | General |
| 12/12/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: PAIN | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $78.02 | General |
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: EPILEPSY | ||||||
| 12/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $12.41 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 693 | 31,610 | $654,905 | $260,604 |
| 2022 | 12 | 606 | 28,897 | $549,016 | $225,461 |
| 2021 | 16 | 565 | 20,645 | $423,820 | $179,886 |
| 2020 | 18 | 661 | 15,192 | $381,348 | $151,538 |
Total Patients
2,525
Total Services
96,344
Medicare Billing
$817,489
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 71 | 30,800 | $369,600 | $151,169 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 248 | $66,216 | $25,021 | 37.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 72 | 154 | $53,900 | $19,513 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 89 | $33,286 | $12,754 | 38.3% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2023 | 37 | 48 | $28,500 | $12,158 | 42.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 25 | 25 | $25,073 | $10,198 | 40.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 43 | 43 | $19,565 | $7,394 | 37.8% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 30 | 30 | $13,500 | $6,950 | 51.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 17 | 18 | $15,354 | $6,337 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 89 | $16,821 | $4,623 | 27.5% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Office | 2023 | 31 | 31 | $9,906 | $4,052 | 40.9% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 16 | 35 | $3,185 | $435.12 | 13.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 65 | 28,090 | $318,700 | $134,970 | 42.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 65 | 141 | $49,350 | $17,658 | 35.8% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2022 | 49 | 52 | $44,200 | $13,418 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 206 | $32,375 | $13,223 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 65 | $18,863 | $8,781 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 83 | $17,397 | $7,779 | 44.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 21 | 21 | $16,863 | $7,437 | 44.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 23 | 122 | $10,364 | $6,305 | 60.8% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Office | 2022 | 47 | 47 | $14,248 | $5,888 | 41.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 14 | 14 | $12,614 | $5,689 | 45.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $11,403 | $3,929 | 34.5% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 16 | 29 | $2,639 | $383.60 | 14.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 38 | 19,820 | $218,020 | $96,800 | 44.4% |
About Dr. Bilal Choudry, M.D
Dr. Bilal Choudry, M.D is a Epilepsy healthcare provider based in Carlsbad, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396921144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bilal Choudry, M.D has received a total of $345,139 in payments from pharmaceutical and medical device companies, with $65,056 received in 2024. These payments were reported across 2,240 transactions from 70 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($217,562).
As a Medicare-enrolled provider, Choudry has provided services to 2,525 Medicare beneficiaries, totaling 96,344 services with total Medicare billing of $817,489. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology
- Location Carlsbad, CA
- Active Since 01/10/2008
- Last Updated 09/10/2025
- Taxonomy Code 2084E0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396921144
Products in Payments
- APTIOM (Drug) $86,358
- Briviact (Drug) $52,272
- UBRELVY (Drug) $23,708
- EPIDIOLEX (Drug) $23,194
- XCOPRI (Drug) $21,563
- VNS Therapy (Device) $21,366
- Nayzilam (Drug) $19,172
- QULIPTA (Drug) $18,690
- BOTOX (Biological) $14,847
- Cenobamate (Drug) $10,356
- Fycompa (Drug) $9,845
- SYMPAZAN (Drug) $7,320
- Fintepla (Drug) $4,416
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $3,594
- VNS Therapy SenTiva Model 1000 Generator (Device) $1,667
- NURTEC ODT (Drug) $1,505
- RNS System (Device) $1,245
- EMGALITY (Drug) $756.20
- Aimovig (Biological) $686.23
- VALTOCO (Drug) $602.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.